Meda(Pharmaceuticals) Overview
- Status
-
Acquired/Merged
- Employees
-
4,500
- Latest Deal Type
-
M&A
- Financing Rounds
-
8
- Investments
-
32
Meda(Pharmaceuticals) General Information
Description
Manufacturer of pharmaceutical products intended for the treatment and management of various medical conditions. The company offers a portfolio of branded and generic medicines supported by regulatory, marketing, and distribution capabilities, enabling healthcare providers and patients to access effective and reliable therapeutic services.
Contact Information
Website
www.meda.seCorporate Office
- Pipers Väg 2A
- 170 09 Solna
- Sweden
Corporate Office
- Pipers Väg 2A
- 170 09 Solna
- Sweden
Meda(Pharmaceuticals) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Meda(Pharmaceuticals) Comparisons
Industry
Financing
Details
Meda(Pharmaceuticals) Competitors (81)
One of Meda(Pharmaceuticals)’s 81 competitors is LNK International, a Corporation company based in Hauppauge, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LNK International | Corporation | Hauppauge, NY | ||||
| axicorp | Corporate Backed or Acquired | Friedrichsdorf, Germany | ||||
| Rottendorf Pharma | Corporation | Ennigerloh, Germany | ||||
| Aytu Biopharma | Corporation | Denver, CO | ||||
| Moberg Pharma | Formerly VC-backed | Bromma, Sweden |
Meda(Pharmaceuticals) Patents
Meda(Pharmaceuticals) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202319896-D0 | Oral care preparations | Inactive | 22-Dec-2023 | ||
| AU-2020205463-A1 | Oral care preparations comprising chlorhexidine and arginine or their salts | Inactive | 11-Jan-2019 | ||
| EP-3697380-A1 | Oral care preparations comprising chlorhexidine and arginine or their salts | Active | 11-Jan-2019 | ||
| EP-3697380-B1 | Oral care preparations comprising chlorhexidine and arginine or their salts | Active | 11-Jan-2019 | ||
| EP-3721862-A1 | Oral care preparations comprising chlorhexidine and arginine or their salts | Active | 11-Jan-2019 | A61K8/43 |
Meda(Pharmaceuticals) Signals
Meda(Pharmaceuticals) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Meda(Pharmaceuticals) Investments & Acquisitions (32)
Meda(Pharmaceuticals)’s most recent deal was a Grant with Gtlyfe for . The deal was made on 11-Oct-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Gtlyfe | 11-Oct-2018 | Grant | Application Software | ||
| BCM Holdings | 26-Feb-2017 | Merger/Acquisition | Real Estate Services (B2C) | ||
| Rottapharm | 10-Oct-2014 | Merger/Acquisition | Pharmaceuticals | ||
| Zpearpoint | 19-Dec-2013 | Merger/Acquisition | Pharmaceuticals | ||
| Acton Pharmaceuticals | 21-Oct-2013 | Merger/Acquisition | Pharmaceuticals |
Meda(Pharmaceuticals) Exits (3)
Meda(Pharmaceuticals)’s most recent exit was on 11-Oct-2018 from Gtlyfe. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Gtlyfe | 11-Oct-2018 | Completed |
|
||
| BCM Holdings | 26-Feb-2017 | Completed |
|
||
| Ceplene (exclusive rights) | 01-Jan-2010 | Corporate Asset Purchase | Completed |
Meda(Pharmaceuticals) Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Mylan Sweden Holdings | Stockholm, Sweden | 2016 | |
| MidNite (Pharmaceuticals) | Solna, Sweden | 2002 | |
| Scandinavian Pharmaceuticals-Generics | Stockholm, Sweden | 1983 | |
| Ellem Läkemedel | Danderyd, Sweden | 1978 |
Meda(Pharmaceuticals) FAQs
-
Where is Meda(Pharmaceuticals) headquartered?
Meda(Pharmaceuticals) is headquartered in Solna, Sweden.
-
What is the size of Meda(Pharmaceuticals)?
Meda(Pharmaceuticals) has 4,500 total employees.
-
What industry is Meda(Pharmaceuticals) in?
Meda(Pharmaceuticals)’s primary industry is Pharmaceuticals.
-
Is Meda(Pharmaceuticals) a private or public company?
Meda(Pharmaceuticals) is a Private company.
-
What is the current valuation of Meda(Pharmaceuticals)?
The current valuation of Meda(Pharmaceuticals) is .
-
What is Meda(Pharmaceuticals)’s current revenue?
The current revenue for Meda(Pharmaceuticals) is .
-
How much funding has Meda(Pharmaceuticals) raised over time?
Meda(Pharmaceuticals) has raised $3.06B.
-
Who are Meda(Pharmaceuticals)’s investors?
Fidim, Nordic Capital, Priveq Investment, and Stena Sessan have invested in Meda(Pharmaceuticals).
-
Who are Meda(Pharmaceuticals)’s competitors?
LNK International, axicorp, Rottendorf Pharma, Aytu Biopharma, and Moberg Pharma are some of the 81 competitors of Meda(Pharmaceuticals).
-
When was Meda(Pharmaceuticals) acquired?
Meda(Pharmaceuticals) was acquired on 05-Aug-2016.
-
Who acquired Meda(Pharmaceuticals)?
Meda(Pharmaceuticals) was acquired by Mylan.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process